Get started
HAMLET BIOPHARMA AB SER. BHAMLET BIOPHARMA AB SER. BHAMLET BIOPHARMA AB SER. B

HAMLET BIOPHARMA AB SER. B

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

HAMLET.B fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Hamlet BioPharma AB engages in the research and development of pharmaceutical products focusing on tumor cells. The company was founded by Catharina Svanborg on March 29, 1999 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
HAMLET.B has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company